Evaluation of the VP22 gene adjuvant for enhancement of DNA vaccine against somatostatin in mice

Animal

Volumn 2, Issue 11, 2008, Pages 1569-1574

  Han, Li ^a   Liang, A X ^a   Zhang, J ^a   Fang, M ^a   Hua, G H ^a   Sang, L ^a   Geng, L Y ^a   Wang, H R ^a   Yang, L G ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

BHV 1 VP22; DNA vaccine; Somatostatin

Indexed keywords

ANIMALIA; MUS;

EID: 54349104733     PISSN: 17517311     EISSN: 1751732X     Source Type: Journal    
DOI: 10.1017/S175173110800284X     Document Type: Article

References (22)

1. Ayuk J and Sheppard MC 2006. Growth hormone and its disorders. Postgraduate Medical Journal 82, 24-30.
2. Buonomo FC, Sabacky MJ, Della-Fera MA and Baile CA 1987. Effects of somatostatin immunoneutralization on growth and endocrine parameters in chickens. Domestic Animal Endocrinology 4, 191-200.
3. Calarota S, Bratt G, Nordlund S, Hinkula J, Leandersson AC, Sandstrom E and Wahren B 1998. Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients. Lancet 351, 1320-1325.
4. Davis HL, Weeratna R, Waldschmidt TJ, Tygrett L, Schorr J and Krieg AM 1998. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. Journal of Immunology 160, 870-876.
5. Han L, Mao DG, Zhang DK, Liang AX, Fang M, Moaeen-Ud-Din M and Yang LG 2007. Development and evaluation of a novel DNA vaccine expressing inhibin alpha (1-32) fragment for improving the fertility in rats and sheep. Animal Reproduction Science (Epub ahead of print).
6. Harms JS, Ren X, Oliveira SC and Splitter GA 2000. Distinctions between bovine herpesvirus 1 and herpes simplex virus type 1 VP22 tegument protein subcellular associations. Journal of Virology 74, 3301-3312.
7. Hung CF, Cheng WF, Chai CY, Hsu KF, He L, Ling M and Wu TC 2001. Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen. Journal of Immunology 166, 5733-5740.
8. Hung CF, He L, Juang J, Lin TJ, Ling M and Wu TC 2002. Improving DNA vaccine potency by linking Marek's disease virus type 1 VP22 to an antigen. Journal of Virology 76, 2676-2682.
9. Kim TW, Hung CF, Kim JW, Juang J, Chen PJ, He L, Boyd DA and Wu TC 2004. Vaccination with a DNA vaccine encoding herpes simplex virus type 1 VP22 linked to antigen generates long-term antigen-specific CD8-positive memory T cells and protective immunity. Human Gene Therapy 15, 167-177.
10. Liang X, Chow B, Li Y, Raggo C, Yoo D, Attah-Poku S and Babiuk LA 1995. Characterization of bovine herpesvirus 1 UL49 homolog gene and product: bovine herpesvirus 1 UL49 homolog is dispensable for virus growth. Journal of Virology 69, 3863-3867.
11. Liang A, Cao S, Han L, Yao Y, Moaeen-Ud-Din M and Yang L 2008. Construction and evaluation of the eukaryotic expression plasmid encoding two copies of somatostatin genes fused with hepatitis B surface antigen gene S. Vaccine 26, 2935-2941.
12. MacGregor RR, Boyer JD, Ugen KE, Lacy KE, Gluckman SJ, Bagarazzi ML, Chattergoon MA, Baine Y, Higgins TJ, Ciccarelli RB, Coney LR, Ginsberg RS and Weiner DB 1998. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. Journal of Infectious Diseases 178, 92-100.
13. Michel N, Osen W, Gissmann L, Schumacher TN, Zentgraf H and Muller M 2002. Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination. Virology 294, 47-59.
14. Ohlsson C, Bengtsson BA, Isaksson OG, Andreassen TT and Slootweg MC 1998. Growth hormone and bone. Endocrine Reviews 19, 55-79.
15. Oliveira SC, Harms JS, Afonso RR and Splitter GA 2001. A genetic immunization adjuvant system based on BVP22-antigen fusion. Human Gene Therapy 12, 1353-1359.
16. Saha S, Yoshida S, Ohba K, Matsui K, Matsuda T, Takeshita F, Umeda K, Tamura Y, Okuda K, Klinman D, Xin KQ and Okuda K 2006. A fused gene of nucleoprotein (NP) and herpes simplex virus genes (VP22) induces highly protective immunity against different subtypes of influenza virus. Virology 354, 48-57.
17. Tang DC, DeVit M and Johnston SA 1992. Genetic immunization is a simple method for eliciting an immune response. Nature 356, 152-154.
18. Van Kessel AG, Korchinski RS, Hampton CH and Laarveld B 1990. Effect of immunization against somatostatin in the pregnant ewe on growth and endocrine status of the neonatal lamb. Domestic Animal Endocrinology 7, 217-227.
19. Vance ML, Hartman ML and Thorner MO 1992. Growth hormone and nutrition. Hormone Research 38(suppl 1), 85-88.
20. Wang R, Doolan DL, Le TP, Hedstrom RC, Coonan KM, Charoenvit Y, Jones TR, Hobart P, Margalith M, Ng J, Weiss WR, Sedegah M, de Taisne C, Norman JA and Hoffman SL 1998. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282, 476-480.
21. Wills KN, Atencio IA, Avanzini JB, Neuteboom S, Phelan A, Philopena J, Sutjipto S, Vaillancourt MT, Wen SF, Ralston RO and Johnson DE 2001. Intratumoral spread and increased efficacy of a p53-VP22 fusion protein expressed by a recombinant adenovirus. Journal of Virology 75, 8733-8741.
22. Zheng C, Babiuk LA and van Drunen Littel-van den Hurk S 2005. Bovine herpesvirus 1 VP22 enhances the efficacy of a DNA vaccine in cattle. Journal of Virology 79, 1948-1953.